Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

iTeos Therapeutics

10.15
0.0000
Volume:- -
Turnover:111.74M
Market Cap:448.68M
PE:-2.17
High:10.15
Open:10.15
Low:10.15
Close:10.15
52wk High:17.63
52wk Low:4.80
Shares:44.21M
Float Shares:33.24M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.6756
EPS(LYR):-3.3210
ROE:-34.97%
ROA:-18.49%
PB:0.91
PE(LYR):-3.06

Loading ...

OverviewCompanyNewsFilings

China's Ocean Economy: A Synergistic Rise Towards Maritime Power

Deep News
·
Dec 06, 2025

Vor Biopharma Inc. Appoints Adi Osovsky as General Counsel to Support Strategic Growth

Reuters
·
Sep 02, 2025

Iteos Therapeutics Announces Delisting from Nasdaq Following Merger Completion

Reuters
·
Aug 29, 2025

Iteos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 08, 2025

Iteos Therapeutics Inc expected to post a loss of $1.01 a share - Earnings Preview

Reuters
·
Aug 04, 2025

Wedbush Adjusts Price Target on iTeos Therapeutics to $10.50 From $12, Maintains Neutral Rating

MT Newswires Live
·
Jul 22, 2025

iTeos Therapeutics Agrees to be Acquired by Concentra Biosciences

MT Newswires Live
·
Jul 21, 2025

BRIEF-Iteos Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $10.047 In Cash Per Share Plus A Contingent Value Right

Reuters
·
Jul 21, 2025

Iteos Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 18, 2025

CEO Michel Detheux Reports Disposal of Common Shares of iTeos Therapeutics Inc

Reuters
·
Jun 12, 2025

Analyst Rate

Hold
Buy
0.00%
Hold
100.00%
Sell
0.00%

Corporate Actions

Delist
Sep 02, 2025
Financial Report Announcement
Aug 06, 2025 Pre-Market
Financial Report Announcement
Apr 28, 2025 Post Market
Financial Report Announcement
Mar 05, 2025 Pre-Market
Financial Report Announcement
Nov 12, 2024 Pre-Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-2.17
Current
0.57
Sector Average
58.58%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-2.17
Maximum
112.24
+1 STD
31.07
Minimum
-51.12
-1 STD
-29.93
Average
0.57

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.